Beyond The Printed Page

1. MAPS: Walking The Talk On Intellectual Property? 4/29/2022

   Did MAPS, a leader in the psychedelic medicines space, just make good on its promise to share its intellectual property, as opposed to wielding it against competitors?

2. Where Patients Meet Policy: The EveryLife Foundation For Rare Diseases 4/1/2022

   The year before he founded Ultragenyx, Emil Kakkis created the EveryLife Foundation for Rare Diseases, a nonprofit patient advocacy organization focused on the “equitable development of and access to lifesaving diagnoses, treatments, and cures.” We caught up with Annie Kennedy, chief of policy and advocacy at the EveryLife Foundation, to learn more about the issues and policies the foundation is prioritizing this year.

3. Ever Learn A Lesson The Hard Way? 1/24/2022

   Bernard Coulie, M.D., Ph.D., president and CEO of Pliant Therapeutics, a company developing treatments for fibrotic diseases, shares a lesson learned the hard way involving an exit from a previous startup.

4. Starting A Company … In Another Country 1/17/2022

   Bernard Coulie, M.D., Ph.D., president and CEO of Pliant Therapeutics, a company developing treatments for fibrotic diseases, discusses challenges associated with building a biopharma startup in another country.

5. A Lesson In Leadership From Lara Sullivan 12/22/2021

   Lara Sullivan, M.D., CEO of Pyxis Oncology, shares a story showing the impact had by employees in creating the right corporate culture.

6. The Path That Brought Lara Sullivan To Biopharma 12/20/2021

   Lara Sullivan, M.D., to be featured in an upcoming issue of Life Science Leader, discusses the entrepreneurial path the brought her to the CEO role at Pyxis Oncology.

7. How Trust Based Is Your Joint Venture? 12/13/2021

   In the January 2022 feature article, Lara Sullivan, M.D., CEO of Pyxis Oncology, talks about building her company, doing so in “stealth mode,” and executing a joint venture. Here’s a video snippet of the conversation as a sneak peek for the upcoming article. 

8. From Compliance To Outsourcing — Advice From 4 Biopharma Manufacturing Execs 12/9/2021

   From improving quality and compliance to key outsourcing decisions, five biopharmaceutical execs offer advice on top-of-mind manufacturing topics.

9. From Politics To Industry Reputation – Top Of Mind Topics For Execs In Biopharma 12/8/2021

   From trade relations to industry reputations, five biopharmaceutical executives share their thoughts on top-of-mind topics as we ready for 2022 and beyond.

10. What Trends Are Biopharma Finance Execs Following? 12/7/2021

    Seven finance execs note what trends they are paying closest attention to in 2022 and beyond.